Shah Neeral L, Intagliata Nicolas M, Henry Zachary H, Argo Curtis K, Northup Patrick G
Neeral L Shah, Nicolas M Intagliata, Zachary H Henry, Curtis K Argo, Patrick G Northup, Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia, Charlottesville, VA 22908, United States.
World J Hepatol. 2016 Dec 28;8(36):1617-1622. doi: 10.4254/wjh.v8.i36.1617.
To investigate the incidence of spontaneous bacterial peritonitis (SBP) in pre-transplant patients and its effect on post transplant mortality and graft failure.
We conducted a retrospective cohort study of patient records from the organ procurement and transplant network data set. Patients were identified by the presence of SBP pre-transplant. Univariate post-transplant survival models were constructed using the Kaplan-Meier technique and multivariate models were constructed using the Cox proportional hazards model. Variables that affected post-transplant graft survival were identified in the SBP population.
Forty-seven thousand eight hundred and eighty patient records were included in the analysis for both groups, and 1966 (4.11%) patients were identified in the data set as having pre-transplant SBP. Patients that had pre-transplant SBP had higher rates of graft loss from recurrent hepatitis C virus (HCV) (3.6% 2.0%, < 0.0001), infections leading to graft loss (1.9% 1.3%, = 0.02), primary non-function (4.3% 3.0%, < 0.0001) and chronic rejection (1.1% 0.7%, = 0.04). Kaplan-Meier survival analysis showed a statistically significant difference in all-cause survival in patients with a history of SBP those without ( < 0.0001). Pre-transplant history of SBP was independently predictive of mortality due to recurrent HCV (HR = 1.11, 95%CI: 1.02-1.21, < 0.017) after liver transplantation.
HCV patients prior to the advent of directing acting anti-viral agents had a higher incidence of pre-transplant SBP than other patients on the liver transplant wait list. SBP history pre-transplant resulted in a higher rate of graft loss due to recurrent HCV infection and chronic rejection.
调查移植前患者自发性细菌性腹膜炎(SBP)的发生率及其对移植后死亡率和移植物失功的影响。
我们对器官获取与移植网络数据集中的患者记录进行了一项回顾性队列研究。通过移植前存在SBP来识别患者。使用Kaplan-Meier技术构建单因素移植后生存模型,并使用Cox比例风险模型构建多因素模型。在SBP人群中确定影响移植后移植物存活的变量。
两组分析均纳入了47880份患者记录,数据集中有1966例(4.11%)患者被确定为移植前患有SBP。移植前患有SBP的患者因丙型肝炎病毒(HCV)复发导致移植物丢失的发生率更高(3.6%对2.0%,P<0.0001),因感染导致移植物丢失的发生率更高(1.9%对1.3%,P=0.02),原发性无功能发生率更高(4.3%对3.0%,P<0.0001)以及慢性排斥反应发生率更高(1.1%对0.7%,P=0.04)。Kaplan-Meier生存分析显示,有SBP病史的患者与无SBP病史的患者全因生存率存在统计学显著差异(P<0.0001)。移植前SBP病史是肝移植后因HCV复发导致死亡的独立预测因素(风险比=1.11,95%置信区间:1.02-1.21,P<0.017)。
在直接作用抗病毒药物出现之前,HCV患者移植前SBP的发生率高于肝移植等待名单上的其他患者。移植前SBP病史导致因HCV感染复发和慢性排斥反应而导致移植物丢失的发生率更高。